Artificial Intelligence Generative AI Innovation Pharmaceuticals 
CIO
MAY 5, 2023
Artificial intelligence (AI), an increasingly crucial piece of the technology landscape, has arrived. More than 91 percent of businesses surveyed have ongoing — and increasing — investments in artificial intelligence. Retailers typically use AI differently than pharmaceutical companies.
AWS Machine Learning - AI
FEBRUARY 6, 2024
Bringing innovative new pharmaceuticals drugs to market is a long and stringent process. Accenture built a regulatory document authoring solution using automated generative AI that enables researchers and testers to produce CTDs efficiently. AI delivers a major leap forward.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CIO
DECEMBER 18, 2023
Over the summer, I wrote a column about how CIOs are worried about the informal rise of generative AI in the enterprise. Since then, many CIOs I’ve spoken with have grappled with enterprise data security and privacy issues around AI usage in their companies. That column may have been the understatement of the year.
Existek
OCTOBER 18, 2023
In this article, we’ll discuss the topic of generative AI in healthcare and how it’s transforming this vital industry. List of the Content What is generative AI? How is generative AI transforming healthcare? Challenges of generative AI in healthcare Conclusion WHAT IS GENERATIVE AI?
CIO
NOVEMBER 9, 2023
As countless organizations race to investigate or adopt artificial intelligence technologies, many are building out an AI skilled workforce. That includes the decision to appoint or hire a chief artificial intelligence officer (CAIO).
CIO
APRIL 4, 2024
Some prospective projects require custom development using large language models (LLMs), but others simply require flipping a switch to turn on new AI capabilities in enterprise software. “AI For example, it’s experimenting with using gen AI to automatically read financial statements from corporate customers when assessing loan applications.
CIO
DECEMBER 14, 2023
Caveat emptor in the cloud Bob McGowan, CIO of Regeneron Pharmaceuticals, acknowledges the risk of cloud concentration is valid but he is more concerned about the readiness of SaaS partners. “If As for the AI question, this CIO’s approach mirrors that of many CIOs today. “We
Expert insights. Personalized for you.
227 
Let's personalize your content